TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biopharmacon, AB
Closing information (x1000 SEK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
480
|
382
|
243 |
| Financial expenses |
5
|
0
|
61 |
| Earnings before taxes |
225
|
21
|
2,053 |
| EBITDA |
62
|
-35
|
16 |
| Total assets |
7,075
|
6,807
|
6,790 |
| Current assets |
6,659
|
6,386
|
6,369 |
| Current liabilities |
166
|
86
|
67 |
| Equity capital |
6,826
|
6,650
|
6,637 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
96.5%
|
97.7%
|
97.7% |
| Turnover per employee |
480
|
382
|
243 |
| Profit as a percentage of turnover |
46.9%
|
5.5%
|
844.9% |
| Return on assets (ROA) |
3.3%
|
0.3%
|
31.1% |
| Current ratio |
4011.4%
|
7425.6%
|
9506.0% |
| Return on equity (ROE) |
3.3%
|
0.3%
|
30.9% |
| Change turnover |
98
|
139
|
-168 |
| Change turnover % |
26%
|
57%
|
-41% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.